Rare Cancers (non-specific)

Posted 1 year ago by Wales Gene Park

Researchers are looking at new ways to treat cancer. An area that they are looking at is personalised therapy. Cancer cells have changes in their genes (DNA) that make them different from normal cells. These changes mean that they behave differently. It can also make one person’s cancer different to another’s. A technique called genomic profiling can scan the genes of the cancer and identify those changes. Doctors hope they can match a treatment to your individual cancer. The main aim of this trial is to find out whether personalised therapy is better than chemotherapy for people with CUP.

 Rare Cancers (non-specific) /  Cardiff

Posted 1 year ago by Wales Gene Park

MICROBIOME- A study of MRx0518 before surgery for solid tumours This study is looking at a new treatment called MRx0518 for solid tumours.

 Rare Cancers (non-specific) /  London

Posted 1 year ago by Wales Gene Park

A trial looking at lenvatinib and pembrolizumab for people with advanced solid tumours (LEAP-005) This trial is for people with one of the following solid tumours : breast cancer whose cells don’t have receptors for the protein Her2 and the hormones oestrogen and progesterone (triple negative breast cancer) ovarian cancer stomach cancer bowel cancer a type of brain tumour called glioblastoma multiforme (GBM) bile duct cancer gallbladder cancer It is for people whose cancer continued to grow or spread to other parts of the body despite treatment (advanced solid tumours). The main aims of this trial are to: find out how well lenvatinib and pembrolizumab work as a treatment for advanced solid tumours learn more about the side effects

 Rare Cancers (non-specific) /  London


No post found